1
|
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu
Y, Zhang L, Fan G, Xu J, Gu X, et al: Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet.
395:497–506. 2020.PubMed/NCBI View Article : Google Scholar
|
2
|
Bhurwal A, Minacapelli CD, Orosz E, Gupta
K, Tait C, Dalal I, Zhang C, Zhao E and Rustgi VK: COVID-19 status
quo: Emphasis on gastrointestinal and liver manifestations. World J
Gastroenterol. 27:7969–7981. 2021.PubMed/NCBI View Article : Google Scholar
|
3
|
Georgakopoulou VE, Gkoufa A, Damaskos C,
Papalexis P, Pierrakou A, Makrodimitri S, Sypsa G, Apostolou A,
Asimakopoulou S, Chlapoutakis S, et al: COVID-19-associated acute
appendicitis in adults. A report of five cases and a review of the
literature. Exp Ther Med. 24(482)2022.PubMed/NCBI View Article : Google Scholar
|
4
|
Weber S, Hellmuth JC, Scherer C,
Muenchhoff M, Mayerle J and Gerbes AL: Liver function test
abnormalities at hospital admission are associated with severe
course of SARS-CoV-2 infection: A prospective cohort study. Gut.
70:1925–1932. 2021.PubMed/NCBI View Article : Google Scholar
|
5
|
Cholongitas E, Bali T, Georgakopoulou VE,
Giannakodimos A, Gyftopoulos A, Georgilaki V, Gerogiannis D,
Basoulis D, Eliadi I, Karamanakos G, et al: Prevalence of abnormal
liver biochemistry and its impact on COVID-19 patients' outcomes: A
single-center Greek study. Ann Gastroenterol. 35:290–296.
2022.PubMed/NCBI View Article : Google Scholar
|
6
|
Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y,
Li Z, Zhou G, Gou J, Qu J, et al: COVID-19: Abnormal liver function
tests. J Hepatol. 73:566–574. 2020.PubMed/NCBI View Article : Google Scholar
|
7
|
Sobotka LA, Esteban J, Volk ML, Elmunzer
BJ and Rockey DC: North American Alliance for the Study of
Digestive Manifestation of COVID-19*. Acute liver injury in
patients hospitalized with COVID-19. Dig Dis Sci. 67:4204–4214.
2022.PubMed/NCBI View Article : Google Scholar
|
8
|
Ekpanyapong S, Bunchorntavakul C and Reddy
KR: COVID-19 and the liver: Lessons learnt from the EAST and the
WEST, a year later. J Viral Hepat. 29:4–20. 2022.PubMed/NCBI View Article : Google Scholar
|
9
|
Bernstein D, Roth N, Kim A, Epstein M,
Hirschwerk D, Kvasnovsky CL and Satapathy SK: Presentation,
patterns and predictive value of baseline liver tests on outcomes
in COVID-19 patients without chronic liver disease. World J
Gastroenterol. 27:7350–7361. 2021.PubMed/NCBI View Article : Google Scholar
|
10
|
Gurala D, Al Moussawi H, Philipose J and
Abergel JR: Acute liver failure in a COVID-19 patient without any
preexisting liver disease. Cureus. 12(e10045)2020.PubMed/NCBI View Article : Google Scholar
|
11
|
Gan Q, Gong B, Sun M, Cao Z, Zheng Y,
Zhang Y, Wen P, Shen Y, Hong L, Hou T, et al: A high percentage of
patients recovered from COVID-19 but discharged with abnormal liver
function tests. Front Physiol. 12(642922)2021.PubMed/NCBI View Article : Google Scholar
|
12
|
Robles-Diaz M, Lucena MI, Kaplowitz N,
Stephens C, Medina-Cáliz I, González-Jimenez A, Ulzurrun E,
Gonzalez AF, Fernandez MC, Romero-Gómez M, et al: Use of Hy's law
and a new composite algorithm to predict acute liver failure in
patients with drug-induced liver injury. Gastroenterology.
147:109–118. 2014.PubMed/NCBI View Article : Google Scholar
|
13
|
Hanley JA and McNeil BJ: A method of
comparing the areas under receiver operating characteristic curves
derived from the same cases. Radiology. 148:839–843.
1983.PubMed/NCBI View Article : Google Scholar
|
14
|
Pellegrini JR Jr, Sabbula B, Russe-Russe
JR, Munshi RF, Meshoyrer D, Sajid N, Gutierrez A, Munnangi S,
Szydziak E and Akella J: A retrospective analysis of
COVID-19-infected patients with acute hepatitis who develop acute
liver failure in a safety net hospital. BMJ Open Gastroenterol.
8(e000738)2021.PubMed/NCBI View Article : Google Scholar
|
15
|
Melquist S, Estepp K, Aleksandrovich Y,
Lee A, Beiseker A, Hamedani FS and Bassett J: COVID-19 presenting
as fulminant hepatic failure: A case report. Medicine (Baltimore).
99(e22818)2020.PubMed/NCBI View Article : Google Scholar
|
16
|
Chew M, Tang Z, Radcliffe C, Caruana D,
Doilicho N, Ciarleglio MM, Deng Y and Garcia-Tsao G: Significant
liver injury during hospitalization for COVID-19 is not associated
with liver insufficiency or death. Clin Gastroenterol Hepatol.
19:2182–2191. 2021.PubMed/NCBI View Article : Google Scholar
|
17
|
Paštrovic F, Lucijanic M, Atic A, Stojic
J, Barisic Jaman M, Tjesic Drinkovic I, Zelenika M, Milosevic M,
Medic B, Loncar J, et al: Prevalence and prognostic impact of
deranged liver blood tests in COVID-19: Experience from the
regional COVID-19 center over the cohort of 3812 hospitalized
patients. J Clin Med. 10(4222)2021.PubMed/NCBI View Article : Google Scholar
|
18
|
Krishnan A, Prichett L, Tao X, Alqahtani
SA, Hamilton JP, Mezey E, Strauss AT, Kim A, Potter JJ, Chen PH and
Woreta TA: Abnormal liver chemistries as a predictor of COVID-19
severity and clinical outcomes in hospitalized patients. World J
Gastroenterol. 28:570–587. 2022.PubMed/NCBI View Article : Google Scholar
|
19
|
Medetalibeyoglu A, Catma Y, Senkal N,
Ormeci A, Cavus B, Kose M, Bayramlar OF, Yildiz G, Akyuz F,
Kaymakoglu S and Tukek T: The effect of liver test abnormalities on
the prognosis of COVID-19. Ann Hepatol. 19:614–621. 2020.PubMed/NCBI View Article : Google Scholar
|